Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Li Ning (2331.HK)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (HK$)	Price Target (HK$)	Rating
2022-02-28	77.65	112.80	Buy
2022-03-18	60.60	101.80	Buy
2022-04-20	61.90	92.00	Buy
2022-05-19	58.65	82.90	Buy
2022-08-12	70.10	87.00	Buy
2022-10-19	52.95	79.00	Buy
2023-02-20	70.50	90.00	Buy
2023-03-18	57.70	81.50	Buy
2023-04-20	57.40	84.00	Buy
2023-07-17	42.30	58.00	Buy
2023-10-26	23.95	43.00	Buy
2023-11-03	27.55	39.00	Buy
2024-01-06	18.84	21.00	Neutral
2024-03-20	21.45	23.00	Neutral
2024-08-16	13.10	14.30	Neutral
2025-01-13	14.66	15.90	Neutral
2025-03-29	17.16	17.60	Neutral
2025-04-28	15.00	15.70	Neutral

Disclosures

UBS Securities Hong Kong Limited is a market maker in the Hong Kong-listed securities of this company.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.